What Is Gene Editing? A Plain-English Guide

Gene Editing in Simple Terms

Gene editing is a set of technologies that allow scientists to change an organism's DNA. Think of DNA as an instruction manual that tells your cells how to function. Gene editing lets researchers find a specific section of that manual and rewrite, remove, or replace it.

This is significant because many diseases are caused by errors in DNA — sometimes just a single misplaced letter in a genetic code that's billions of letters long. Gene editing offers the potential to correct those errors at their source, rather than just treating symptoms.

How Does Gene Editing Work?

At its core, gene editing works in three basic steps:

1. Find the target. A molecular guide navigates to the exact location in your DNA that needs to be changed.
2. Cut or modify. A molecular tool (like an enzyme) makes a precise cut or chemical change at that location.
3. Let the cell repair. The cell's natural repair processes fix the cut — either by deleting the faulty section, correcting it, or inserting a new sequence.

Different gene editing tools approach these steps in slightly different ways, but the overall concept remains the same: find the problem, fix it at the genetic level.

Types of Gene Editing Technologies

CRISPR-Cas9

CRISPR (Clustered Regularly Interspaced Short Palindromic Repeats) is the most well-known gene editing tool. It uses a guide RNA to find a specific DNA sequence and an enzyme called Cas9 to cut it. CRISPR is faster, cheaper, and more accurate than previous methods, which is why it has dominated headlines since its development in 2012.

Base Editing

Base editing is a newer, more refined approach. Instead of cutting DNA and relying on the cell to repair itself, base editors chemically convert one DNA letter into another without making a cut. This reduces the risk of unintended changes.

Prime Editing

Prime editing is sometimes called "search and replace" for DNA. It can make virtually any small change to DNA without cutting both strands, making it one of the most precise gene editing tools available.

Older Methods: ZFNs and TALENs

Before CRISPR, scientists used zinc finger nucleases (ZFNs) and TALENs. These tools work on similar principles but are more expensive and time-consuming to design. They're still used in some clinical applications but have largely been overtaken by CRISPR-based approaches.

What Can Gene Editing Treat?

Gene editing is being researched and, in some cases, applied across a wide range of conditions:

• Blood disorders — Sickle cell disease and beta-thalassemia were among the first conditions treated with CRISPR-based therapies.
• Cancer — Researchers are editing immune cells to better recognize and attack tumors.
• Eye diseases — Inherited retinal diseases are being targeted with gene editing delivered directly to the eye.
• Rare genetic disorders — Conditions caused by single-gene mutations are prime candidates for gene editing approaches.
• Neuromuscular conditions — Duchenne muscular dystrophy and similar conditions are active areas of research.
• Infectious diseases — Gene editing is being explored as a way to make cells resistant to viruses like HIV.

Gene Editing vs. Gene Therapy: What's the Difference?

These terms are often used interchangeably, but they mean different things:

• Gene therapy adds a new, working copy of a gene to compensate for a faulty one. The original gene is still there.
• Gene editing changes the existing gene directly — correcting, disabling, or modifying it in place.

Gene editing is generally considered more precise because it targets the root cause rather than working around it. However, both approaches have valid applications depending on the condition being treated.

For a deeper comparison, see our guide: Gene Editing vs. Gene Therapy

Is Gene Editing Safe?

Gene editing technologies have advanced rapidly, but safety is still the central question. Key considerations include:

• Off-target effects: The editing tool might change DNA in unintended locations. Newer tools like base editing and prime editing are designed to minimize this risk.
• Delivery challenges: Getting the editing tools to the right cells in the body remains a technical hurdle.
• Long-term effects: Because gene editing is relatively new, long-term data is still being collected through clinical trials and follow-up studies.
• Regulatory oversight: Gene editing therapies must pass rigorous clinical trials and regulatory review before being approved for patient use.

Gene Editing in Clinical Trials

As of 2026, dozens of gene editing clinical trials are underway worldwide. The first CRISPR-based therapy — for sickle cell disease and beta-thalassemia — received regulatory approval in late 2023, marking a milestone for the field.

Clinical trials are the pathway through which new gene editing treatments are tested and eventually made available to patients. They're conducted in phases, each designed to answer specific questions about safety and effectiveness.

Learn more about how clinical trials work and how to explore options: Clinical Trials for Gene Therapy

The Future of Gene Editing

Gene editing is still in its early stages, but the trajectory is clear. Researchers are working on:

• More precise editing tools with fewer off-target effects
• Better delivery systems to reach more types of cells and organs
• Treatments for a wider range of conditions, including common diseases
• Combining gene editing with other therapies like immunotherapy

The field is evolving quickly, and new breakthroughs are being announced regularly. Staying informed is one of the most important things patients and families can do.